Positive results from its Phase III STEER study mean Novartis could boost sales of its OAV101 IT drug for spinal muscular ...

Spinal muscular atrophy, SMA, a genetic neuromuscular disorder with progressive muscle wasting due to mutation in the SMN1 gene, deficiency in SMN protein, and loss of motor neurons, 3D illustration ...

Share on Pinterest How much protein you need to build muscle can depend on your weight, activity level, and age. Eating too much may have some risks. Getty Images/Alexander Spatari Protein is ...

Investing.com -- Novartis AG (SIX:NOVN) has reported that an advanced study showed their new experimental drug improved motor function in children suffering from a form of spinal muscular atrophy. The ...

Investing.com -- Novartis AG (SIX:NOVN) has reported that an advanced study showed their new experimental drug improved motor function in children suffering from a form of spinal muscular atrophy.

The finding is particularly significant for those suffering from incomplete spinal ... show improvement, those with incomplete injuries (where some nerve pathways remain intact) demonstrated ...